FDA

Pricking your fingers may someday be a thing of the past for diabetics as new technologies aim to make blood sugar regulation more convenient.

Diabetes Technology Moves Closer To Making Life Easier For Patients

1:49pm October 18, 2017

by Miriam E. Tucker

While the technology is moving rapidly, insurance, regulatory, and supply challenges make it harder for patients to quickly access the latest medical advances to manage their condition.

Manufacturers are not required to disclose if BPA, or other similar compounds, are used in their packaging.

Health & Safety

Which Items In Our Kitchens Contain BPA?

7:00am October 06, 2017

by Natalie Jacewicz

Manufacturers are not required to disclose whether products contain BPA, which makes it hard to know which kitchen plastics include the additive — or other functionally identical compounds.

A recent test by dermatologists found that 83 percent of the top-selling moisturizers that are labeled "hypoallergenic"contained a potentially allergenic chemical.

'Hypoallergenic' And 'Fragrance-Free' Moisturizer Claims Are Often False

1:01pm October 02, 2017

by Patti Neighmond

People with skin conditions like eczema need moisturizers to treat their dry, cracked and reddened skin. But research suggests many moisturizers are mislabeled and can make the skin conditions worse.

Queue Listen Now

British American Tobacco Ends Contract With Tech Firm Producing 'Low-Nicotine' Cigarettes

10:31am September 27, 2017

by Sean Bueter

British American Tobacco has ended a contract with a biotechnology firm doing nicotine science with ties to the Piedmont.

The blood-sucking conenose assassin bug (Triatoma sanguisuga) is also called a "kissing bug" because of its tendency to bite human faces. It feeds on human blood and is the vector of the parasite Trypanosoma cruzi, which causes Chagas disease.

Drug For 'Neglected' Chagas Disease Gains FDA Approval Amid Price Worries

6:00am September 10, 2017

by Courtney Columbus

U.S. doctors treating Chagas disease have long wanted FDA approval for a treatment that's widely used in Latin America. But when Martin Shkreli took interest, those doctors panicked — then mobilized.

Adult stem cells can be extracted from human fat.

FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments

2:31pm August 28, 2017

by Rob Stein

The companies are "unscrupulous actors" marketing stem-cell treatments that have not been proved effective and may be dangerous, the FDA says. It took action against clinics in Florida and California.

Amanda Chaffin comforts son Kayden, 4, who has a genetic condition called spinal muscular atrophy, or SMA, and depends on a ventilator to breathe. Chaffin is worried about the high costs of Kayden's care.

Drug Puts A $750,000 'Price Tag On Life'

1:05pm August 01, 2017

by Julie Appleby

The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.

The FDA says it's considering lowering the amount of nicotine in tobacco products, in an attempt to lower the rates of dangerous addiction.

FDA Proposes Cutting Nicotine Amounts In Cigarettes, Targeting Addiction

1:52pm July 28, 2017

by Bill Chappell

It would be the first time in the agency's history that it has sought to regulate the amount of nicotine in cigarettes.

A new drug to treat multiple sclerosis has proven effective, but there are many things to consider before switching to a new treatment plan.

There's An Amazing New Drug For Multiple Sclerosis. Should I Try It?

11:31am July 14, 2017

by Brandie Jefferson

The innovative drug Ocrevus looks as if it could be a game-changer for people with MS. But it's very, very expensive. And as with any new medication, the long-term safety risks are unknown.

Image of a CAR-T cell (reddish) attacking a leukemia cell (green). These CAR-T lymphocytes are used for immunotherapy against cancer (CAR stands for chimeric antigen receptor). After the proliferation of the CAR-expressing T cells, they are transfused bac

'Living Drug' That Fights Cancer By Harnessing Immune System Clears Key Hurdle

10:36am July 13, 2017

by Rob Stein

An advisory panel to the Food and Drug Administration recommends the agency, for the first time, approve a new kind of treatment that uses genetically modified immune cells to attack cancer cells.

Queue Listen Now